Translocation of non-natural chemical entities through anthrax protective antigen pore
US-9498538-B2 · Nov 22, 2016 · US
US9045527B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9045527-B2 |
| Application number | US-201313916359-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 12, 2013 |
| Priority date | Jun 12, 2012 |
| Publication date | Jun 2, 2015 |
| Grant date | Jun 2, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods for targeting a protein by providing an inhibitor covalently linked to a rhodium(II) complex, introducing the inhibitor to the target protein and allowing the inhibitor and protein to interact. The rhodium(II) complex covalently linked to the inhibitor binds the target protein both inorganically and organically and forms stabilizing secondary contacts between the rhodium(II) complex and the protein.
Opening claim text (preview).
What is claimed is: 1. A method comprising: introducing to a target protein a compound comprising a peptide ligand from the PDZ domain of a cystic fibrosis transmembrane conductance regulator (CFTR)-associated ligand wherein the peptide ligand is covalently linked to a rhodium(II) complex and wherein the compound binds to the target protein and form stabilizing secondary contacts between the rhodium(II) complex and the target protein. 2. A method comprising: introducing to a target protein a compound comprising a peptide covalently linked to a rhodium(II) complex, wherein the peptide comprises a sequence selected from the group consisting of SEQ ID NO: 7, SEQ ID NO: 8, and SEQ ID NO: 15, and wherein the compound binds to the target protein and forms stabilizing secondary contacts between the rhodium(II) complex and the target protein. 3. The method of claim 2 , wherein the sequence is SEQ ID NO: 7. 4. The method of claim 2 , wherein the sequence is SEQ ID NO: 8. 5. The method of claim 2 , wherein the sequence is SEQ ID NO: 15.
by chemical modification of precursor peptides · CPC title
by covalent attachment of amino acids or peptide residues · CPC title
Human Necessities · mapped topic
the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.